Chen M - Search Results

1

Identification of novel inhibitors of Aurora A with a 3-(pyrrolopyridin-2-yl)indazole scaffold.

Song P, Chen M, Ma X, Xu L, Liu T, Zhou Y, Hu Y. Song P, et al. Among authors: chen m. Bioorg Med Chem. 2015 Apr 15;23(8):1858-68. doi: 10.1016/j.bmc.2015.02.004. Epub 2015 Feb 13. Bioorg Med Chem. 2015. PMID: 25771484

2

Synthesis and anticancer activity of novel quinoline-docetaxel analogues.

Chen M, Chen H, Ma J, Liu X, Zhang S. Chen M, et al. Among authors: chen h. Bioorg Med Chem Lett. 2014 Jul 1;24(13):2867-70. doi: 10.1016/j.bmcl.2014.04.091. Epub 2014 May 4. Bioorg Med Chem Lett. 2014. PMID: 24835987

3

Design, synthesis, and evaluation of 2-piperidone derivatives for the inhibition of β-amyloid aggregation and inflammation mediated neurotoxicity.

Li L, Chen M, Jiang FC. Li L, et al. Among authors: chen m. Bioorg Med Chem. 2016 Apr 15;24(8):1853-65. doi: 10.1016/j.bmc.2016.03.010. Epub 2016 Mar 4. Bioorg Med Chem. 2016. PMID: 26972922

4

Discovery of small molecule FLT3 inhibitors that are able to overcome drug-resistant mutations.

Zhang G, Zhang W, Shen C, Nan J, Chen M, Lai S, Zhong J, Li B, Wang T, Wang Y, Yang S, Li L. Zhang G, et al. Among authors: chen m. Bioorg Med Chem Lett. 2020 Nov 15;30(22):127532. doi: 10.1016/j.bmcl.2020.127532. Epub 2020 Sep 3. Bioorg Med Chem Lett. 2020. PMID: 32891702

5

Chemical synthesis, microbial transformation and biological evaluation of tetrahydroprotoberberines as dopamine D1/D2 receptor ligands.

Ge H, Zhang Y, Yang Z, Qiang K, Chen C, Sun L, Chen M, Zhang J. Ge H, et al. Among authors: chen m, chen c. Bioorg Med Chem. 2019 May 15;27(10):2100-2111. doi: 10.1016/j.bmc.2019.04.014. Epub 2019 Apr 8. Bioorg Med Chem. 2019. PMID: 30981605

6

Discovery of 3,3-di(indolyl)indolin-2-one as a novel scaffold for α-glucosidase inhibitors: In silico studies and SAR predictions.

Wang G, Wang J, Xie Z, Chen M, Li L, Peng Y, Chen S, Li W, Deng B. Wang G, et al. Among authors: chen m, chen s. Bioorg Chem. 2017 Jun;72:228-233. doi: 10.1016/j.bioorg.2017.05.006. Epub 2017 May 3. Bioorg Chem. 2017. PMID: 28482263

7

Synthesis, in vitro α-glucosidase inhibitory activity and docking studies of novel chromone-isatin derivatives.

Wang G, Chen M, Qiu J, Xie Z, Cao A. Wang G, et al. Among authors: chen m. Bioorg Med Chem Lett. 2018 Jan 15;28(2):113-116. doi: 10.1016/j.bmcl.2017.11.047. Epub 2017 Nov 28. Bioorg Med Chem Lett. 2018. PMID: 29208524

8

Synthesis, biological evaluation and molecular docking studies of chromone hydrazone derivatives as α-glucosidase inhibitors.

Wang G, Chen M, Wang J, Peng Y, Li L, Xie Z, Deng B, Chen S, Li W. Wang G, et al. Among authors: chen m, chen s. Bioorg Med Chem Lett. 2017 Jul 1;27(13):2957-2961. doi: 10.1016/j.bmcl.2017.05.007. Epub 2017 May 5. Bioorg Med Chem Lett. 2017. PMID: 28506754

9

Synthesis, molecular docking and α-glucosidase inhibition of 2-((5,6-diphenyl-1,2,4-triazin-3-yl)thio)-N-arylacetamides.

Wang G, Li X, Wang J, Xie Z, Li L, Chen M, Chen S, Peng Y. Wang G, et al. Among authors: chen m, chen s. Bioorg Med Chem Lett. 2017 Mar 1;27(5):1115-1118. doi: 10.1016/j.bmcl.2017.01.094. Epub 2017 Feb 2. Bioorg Med Chem Lett. 2017. PMID: 28189421

10

Study on binding modes between cellobiose and β-glucosidases from glycoside hydrolase family 1.

Liu L, Zeng Z, Zeng G, Chen M, Zhang Y, Zhang J, Fang X, Jiang M, Lu L. Liu L, et al. Among authors: chen m. Bioorg Med Chem Lett. 2012 Jan 15;22(2):837-43. doi: 10.1016/j.bmcl.2011.12.053. Epub 2011 Dec 16. Bioorg Med Chem Lett. 2012. PMID: 22209489

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

51,301 results

Search Page

Filters